4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001628280-19-007955
Chief Scientific Officer acquired 7,218 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Biller Scott Chief Scientific Officer | 2019-06-11 | Option exercise | +7,218 | $2.34 | $16,872 | 33,729 | D |
| Derivatives | |||||||
| Biller Scott Chief Scientific Officer | 2019-06-11 | Option exercise · Stock option (right to buy) | −7,218 | 0 | D | ||
Loading xslF345X03/wf-form4_156045644678438.xml…